Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: Comparison with cardiopulmonary exercise testing

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 2 I, 2000, Pages 487-492

  Miyamoto, Shoichi ^b   Nagaya, Noritoshi ^a   Satoh, Toru ^b   Kyotani, Shingo ^b   Sakamaki, Fumio ^b   Fujita, Masatoshi ^b   Nakanishi, Norifumi ^b   Miyatake, Kunio ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; NORADRENALIN; OXYGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; DISEASE ASSOCIATION; EXERCISE TEST; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; SCORING SYSTEM; WALKING SPEED;

EID: 0034107636     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.2.9906015     Document Type: Article

References (28)

1. Rich, S., D. R. Dantzker, S. M. Ayres, E. H. Bergofsky, B. H. Brundage, K. M. Detre, A. P. Fishman, R. M. Goldring, B. M. Groves, S. K. Koerner, P. C. Levy, L. M. Reid, C. E. Vreim, and G. W. Williams. 1987. Primary pumonary hypertension: a national prospective study. Ann. Intern. Med. 107:216-223.
2. D'Alonzo, G. E., L. A. Gianotti, R. J., Pohil, R. R. Reagle, S. L. DuRee, F. Fuentes, and D. R. Dantzker. 1987. Comparison of progressive exercise performance of normal subjects and patients with primary pulmonary hypertension. Chest 92:57-62.
3. Rhodes J., R. J. Barst, R. P. Garotano, D. G. Thoele, and W. M. Gersony. 1991. Hemodynamic correlates of exercise function in patients with primary pulmonary hypertension. J. Am. Coll. Cardiol. 18:1738-1744.
4. Meyrs, J., L. Gullestad, R. Vagelos, D. Do, D. Bellin, H. Ross, and M. B. Fowler. 1998. Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann. Intern. Med. 129:286-293.
5. Chua, T. P., P. Ponikowski, D. Harrington, S. D. Anker, K. Webb-Peploe, A. L. Clark, P. A. Poole-Wilson, and A. J. Coats. 1997. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J. Am. Coll. Cardiol. 29:1585-1590.
6. Woo, M. A., D. K. Moser, L. W. Stevenson, and W. G. Stevenson. 1997. Six-minute walk test and heart rale variability: lack of association in advanced stages of heart failure. Am. J. Respir. Crit. Care Med. 6: 348-354.
7. Cahalin, L. P., M. A. Mathier, M. J. Semigran, G. W. Dee, and T. G. Di-Salvo. 1996. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 110:325-332.
8. Roul, G., P. Germain, and P. Bareiss. 1948. Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am. Heart J. 136:449-457.
9. Barst, R. J., L. J. Rubin, W. A. Long, M. D. McGoon, S. Rich, D. B. Badesch, B. M. Groves, V. F . Tapson, R. C. Bourge, B. H. Brundage, S. K. Koerner, D. Langleben, C. A. Keller, S. Murali, B. F. Uretsky, L. M. Clayton, M. M. Jobsis, S. D. Blackburn, D. Shortino, and J. W. Crow. 1996. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N. Engl. J. Med. 334:296-301.
10. Hinderliter, A. L., P. W. Willis, R. J. Barst, S. Rich, L. J. Rubin, D. B. Badesch, B. M. Groves, M. D. McGoon, V. F. Tapson, R. C. Bourge, B. H. Brundage, S. K. Koerner, D. Langleben, C. A. Keller, S. Murali, B. F. Uretsky, G. Koch, S. Li, L. M. Clayton, M. M. Jobsis, S. D. Blackburn, J. W. Crow, and W. A. Long. 1997. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Circulation 95:1479-1486.
11. Eysmann, S. B., H. J. Palevsky, N. Reichek, K. Hackney, and P. S. Douglas. 1989. Two-dimensional and doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 80:353-360.
12. Nootens, M., E. Kaufmann, T. Rector, C. Toher, D. Judd, G. S. Francis, and S. Rich. 1995. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J. Am. Coll. Cardiol. 26:1581-1585.
13. McLaughlin, V. V., D. E. Genthner, M. M. Panella, and S. Rich. 1998. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N. Engl. J. Med. 338:273-277.
14. Okano, Y., A. Yoshioka, A. Shimouchi, T. Satoh, and T. Kunieda. 1997. Orally active prostacyclin analogue in primary pulmonary hypertension (letter). Lancet 349:1365.
15. Nagaya, N., M. Uematsu, Y. Okano, T. Satoh, S. Kyotani, F. Sakamaki. N. Nakanishi, K. Miyatake, and T. Kunieda. 1999. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension. J. Am. Coll. Cardiol. 34:1188-1192.
16. Selzer, A., and R. B. Sudrann. 1958. Reliability of the determination of cardiac output in man by means of the Fick principle. Circ. Res. 6: 485-490.
17. Enright, P. L., and D. L. Sherrill. 1998. Reference equations for the six-minute walk in healthy adults. Am. J. Respir. Crit. Care Med. 158:1384-1387.
18. Tamai, J., Y. Kosakai, T. Yoshioka, E. Ohnishi, H. Takaki, Y. Okano, and Y. Kawashima. 1995. Delayed improvement in exercise capacity with restoration of sinoatrial node response in patients after combined treatment with surgical repair for organic heart disease and the Maze procedure for atrial fibrillation. Circulation 91:2392-2399.
19. Wasserman, K., B. J. Whipp, and R. Casaburi. 1986. Respiratory control during exercise. In N. S. Cherniack and J. G. Widdicombe, editors. Handbook of Physiology, Vol. 2. American Physiological Society, Bethesda, MD. 595-619.
20. Yoshimura, M., T. Komori, T. Nakanishi, and H. Takanashi. 1993. Estimation of sulphoconjugated catecholamine concentrations in plasma by high-performance liquid chromatography. Ann. Clin. Biochem. 30: 135-141.
21. Nagaya, N., T. Satoh, M. Uematsu, Y. Okano, S. Kyotani, N. Nakanishi, and T. Kunieda. 1997. Shortening of Doppler-derived deceleration time of early diastolic transmitral flow in the presence of pulmonary hypertension through ventricular interaction. Am. J. Cardiol. 79:1502-1506.
22. Garofano, R. P., and R. J. Barst. 1999. Exercise testing in children with primary pulmonary hypertension. Pediatr. Cardiol. 20:61-64.
23. Anderson, P., and B. Saltin. 1985. Maximal perfusion of skeletal muscle in man. J. Appl. Pnysiol. 366:233-249.
24. Nery, L. E., K. Wasserman, W. French, A. Oren, and J. A. Davis. 1983. Con-trasting cardiovascular and respiratory responses to exercise in mitral valve and chronic obstructive pulmonary diseases. Chest 83:446-453.
25. Guyatt, G. H., M. J, Sullivan, P. J. Thompson, E. L. Fallen, S. O. Pugsley, D. W. Taylor, and L. B. Berman. 1985. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can. Med. Assoc. J. 132:919-923.
26. Sullivan, M. J., M. B. Higginbotham, and F. R. Cobb. 1988. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 77:552-559.
27. D'Alonzo, G. E., R. J. Barst, S. M. Ayres, E. H. Bergofsky, B. H. Brundage, K. M. Detre, A. P. Fishman, R. M. Goldring, B. M. Groves, J. T. Kernis, P. S. Levy, G. G. Pietra, L. M. Reid, J. T. Reeves, S. Rich, C. E. Vreim, G.W. Williams, and M. Wu. 1991. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann. Intern. Med. 115:343-349.
28. Sandoval, J., O. Bauerle, A. Palomar, A. Gomez, M. L. Martinez-Guerra. M. Beltran, and L. Guerrero. 1994. Survival in primary pulmonary hypertension: validation of a prognostic equation. Circulation 89:1733-1744.